GLP-1, acting on its receptor, has physiological actions on multiple target organs: it increases glucose-stimulated insulin secretion in pancreatic beta cells, reduces glucagon secretion by cells, improves insulin sensitivity and reduces food intake.26 In cellular and murine models GLP-1 promotes cell neogenesis and inhibits their apoptosis.27 Insulin secretion induced by GLP-1 is dependent of the glycemia and therefore does not induce hypoglycemia (Fig
The drug is manufactured by Eli Lilly & Co
I'd be detailed if I were you 2
Autism: metabolism, mitochondria, and the microbiome
1 Your First Consultation Your visit starts with a simple conversation about your goals, your health history, and the daily habits that shape your life
It is possible that the anti-inflammatory CRP reductions observed in the STEP and SELECT trials require the full doses used in those studies